I wouldn't tar the whole company with the same brush. Number 1, it's the Novartis Japan arm and 2, one of the unit's employees falsified results. Could happen to any company as large as they are. Anyways, if they are in collaboration with us my advice is - don't bite that hand that feeds you.
Ann: Research Collaboration & Joint Patent with Japanese Company, page-26
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.0¢ | $83.08K | 474.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 376717 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 144077 | 1 |
View Market Depth
| Last trade - 15.41pm 10/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |